Literature DB >> 17288540

Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays.

George S Baillie1, David R Adams, Narinder Bhari, Thomas M Houslay, Suryakiran Vadrevu, Dong Meng, Xiang Li, Allan Dunlop, Graeme Milligan, Graeme B Bolger, Enno Klussmann, Miles D Houslay.   

Abstract

Beta2-ARs (beta2-adrenoceptors) become desensitized rapidly upon recruitment of cytosolic beta-arrestin. PDE4D5 (family 4 cAMP-specific phosphodiesterase, subfamily D, isoform 5) can be recruited in complex with beta-arrestin, whereupon it regulates PKA (cAMP-dependent protein kinase) phosphorylation of the beta2-AR. In the present study, we have used novel technology, employing a library of overlapping peptides (25-mers) immobilized on cellulose membranes that scan the entire sequence of beta-arrestin 2, to define the interaction sites on beta-arrestin 2 for binding of PDE4D5 and the cognate long isoform, PDE4D3. We have identified a binding site in the beta-arrestin 2 N-domain for the common PDE4D catalytic unit and two regions in the beta-arrestin 2 C-domain that confer specificity for PDE4D5 binding. Alanine-scanning peptide array analysis of the N-domain binding region identified severely reduced interaction with PDE4D5 upon R26A substitution, and reduced interaction upon either K18A or T20A substitution. Similar analysis of the beta-arrestin 2 C-domain identified Arg286 and Asp291, together with the Leu215-His220 region, as being important for binding PDE4D5, but not PDE4D3. Transfection with wild-type beta-arrestin 2 profoundly decreased isoprenaline-stimulated PKA phosphorylation of the beta2-AR in MEFs (mouse embryo fibroblasts) lacking both beta-arrestin 1 and beta-arrestin 2. This effect was negated using either the R26A or the R286A mutant form of beta-arrestin 2 or a mutant with substitution of an alanine cassette for Leu215-His220, which showed little or no PDE4D5 binding, but was still recruited to the beta2-AR upon isoprenaline challenge. These data show that the interaction of PDE4D5 with both the N- and C-domains of beta-arrestin 2 are essential for beta2-AR regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17288540      PMCID: PMC1868836          DOI: 10.1042/BJ20070005

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  The next generation of PDE4 inhibitors.

Authors:  Z Huang; Y Ducharme; D Macdonald; A Robichaud
Journal:  Curr Opin Chem Biol       Date:  2001-08       Impact factor: 8.822

2.  Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis.

Authors:  Shawn K Milano; Helen C Pace; You-Me Kim; Charles Brenner; Jeffrey L Benovic
Journal:  Biochemistry       Date:  2002-03-12       Impact factor: 3.162

3.  Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation.

Authors:  M Han; V V Gurevich; S A Vishnivetskiy; P B Sigler; C Schubert
Journal:  Structure       Date:  2001-09       Impact factor: 5.006

Review 4.  The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications.

Authors:  Ronald Frank
Journal:  J Immunol Methods       Date:  2002-09-01       Impact factor: 2.303

5.  Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity.

Authors:  Robert J Lefkowitz; Kristen L Pierce; Louis M Luttrell
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

6.  The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform.

Authors:  S J Yarwood; M R Steele; G Scotland; M D Houslay; G B Bolger
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

7.  Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling.

Authors:  I D Fraser; M Cong; J Kim; E N Rollins; Y Daaka; R J Lefkowitz; J D Scott
Journal:  Curr Biol       Date:  2000-04-06       Impact factor: 10.834

Review 8.  Beta-Arrestins: new roles in regulating heptahelical receptors' functions.

Authors:  P H McDonald; R J Lefkowitz
Journal:  Cell Signal       Date:  2001-10       Impact factor: 4.315

9.  beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking.

Authors:  T A Kohout; F S Lin; S J Perry; D A Conner; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

10.  Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes.

Authors:  Manuela Zaccolo; Tullio Pozzan
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

View more
  36 in total

1.  The RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2017-03-04       Impact factor: 4.315

Review 2.  Extensive shape shifting underlies functional versatility of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Curr Opin Cell Biol       Date:  2013-11-16       Impact factor: 8.382

3.  The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3.

Authors:  Cecile Terrenoire; Miles D Houslay; George S Baillie; Robert S Kass
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

4.  Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5.

Authors:  Xiang Li; George S Baillie; Miles D Houslay
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

Review 5.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

6.  Elucidation of inositol hexaphosphate and heparin interaction sites and conformational changes in arrestin-1 by solution nuclear magnetic resonance.

Authors:  Tiandi Zhuang; Sergey A Vishnivetskiy; Vsevolod V Gurevich; Charles R Sanders
Journal:  Biochemistry       Date:  2010-11-15       Impact factor: 3.162

7.  Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.

Authors:  Xuanzhi Zhan; Alejandro Perez; Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-01-08       Impact factor: 4.315

8.  Regulation of amygdalar PKA by beta-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning.

Authors:  Yuting Li; Haohong Li; Xing Liu; Guobin Bao; Yezheng Tao; Ziyan Wu; Peng Xia; Chunfu Wu; Baoming Li; Lan Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

Review 9.  The structural basis of the arrestin binding to GPCRs.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Mol Cell Endocrinol       Date:  2019-01-28       Impact factor: 4.102

10.  RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2015-08-06       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.